143 related articles for article (PubMed ID: 24258567)
1. Surgical pathology of lung cancer.
Rezaei MK; Nolan NJ; Schwartz AM
Semin Respir Crit Care Med; 2013 Dec; 34(6):770-86. PubMed ID: 24258567
[TBL] [Abstract][Full Text] [Related]
2. CD90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistry.
Kawamura K; Hiroshima K; Suzuki T; Chai K; Yamaguchi N; Shingyoji M; Yusa T; Tada Y; Takiguchi Y; Tatsumi K; Shimada H; Tagawa M
Am J Clin Pathol; 2013 Oct; 140(4):544-9. PubMed ID: 24045552
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
Husain AN; Colby T; Ordonez N; Krausz T; Attanoos R; Beasley MB; Borczuk AC; Butnor K; Cagle PT; Chirieac LR; Churg A; Dacic S; Fraire A; Galateau-Salle F; Gibbs A; Gown A; Hammar S; Litzky L; Marchevsky AM; Nicholson AG; Roggli V; Travis WD; Wick M;
Arch Pathol Lab Med; 2013 May; 137(5):647-67. PubMed ID: 22929121
[TBL] [Abstract][Full Text] [Related]
4. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.
Attanoos RL; Thomas DH; Gibbs AR
Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258
[TBL] [Abstract][Full Text] [Related]
5. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.
Ordóñez NG
Am J Clin Pathol; 1998 Jan; 109(1):85-9. PubMed ID: 9426522
[TBL] [Abstract][Full Text] [Related]
6. Expression of thrombomodulin, calretinin, cytokeratin 5/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma.
Comin CE; Novelli L; Cavazza A; Rotellini M; Cianchi F; Messerini L
Tumori; 2014; 100(5):559-67. PubMed ID: 25343553
[TBL] [Abstract][Full Text] [Related]
7. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
8. Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Carbone M; Shimizu D; Napolitano A; Tanji M; Pass HI; Yang H; Pastorino S
Oncotarget; 2016 Sep; 7(37):59314-59321. PubMed ID: 27447750
[TBL] [Abstract][Full Text] [Related]
9. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 1998 Oct; 22(10):1215-21. PubMed ID: 9777983
[TBL] [Abstract][Full Text] [Related]
10. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic surgical pathology in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Schwartz AM; Rezaei MK
Chest; 2013 May; 143(5 Suppl):e251S-e262S. PubMed ID: 23649441
[TBL] [Abstract][Full Text] [Related]
12. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
Yuasa H; Tomoyasu M
Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K
Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
[TBL] [Abstract][Full Text] [Related]
14. [Considerations upon diagnosis and treatment of lung and pleural tumors in Mures county].
Jimborean G; Gabor M; Szilai D
Pneumologia; 2001; 50(3):148-53. PubMed ID: 11977485
[TBL] [Abstract][Full Text] [Related]
15. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura.
Miettinen M; Sarlomo-Rikala M
Am J Surg Pathol; 2003 Feb; 27(2):150-8. PubMed ID: 12548160
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Aquaporin-1 in lung adenocarcinomas and pleural mesotheliomas.
López-Campos JL; Sánchez Silva R; Gómez Izquierdo L; Márquez E; Ortega Ruiz F; Cejudo P; Barrot Cortés E; Toledo Aral JJ; Echevarría M
Histol Histopathol; 2011 Apr; 26(4):451-9. PubMed ID: 21360438
[TBL] [Abstract][Full Text] [Related]
17. On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016).
Pira E; Boffetta P; Ciocan C
Tumori; 2019 Aug; 105(4):359-360. PubMed ID: 31418338
[No Abstract] [Full Text] [Related]
18. On the diagnosis of malignant pleural mesothelioma: a necropsy-based study of 171 cases (1997-2016).
Barbieri PG
Tumori; 2019 Aug; 105(4):361-362. PubMed ID: 30592233
[No Abstract] [Full Text] [Related]
19. Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: trends in Australia and a literature review.
Linton A; Kao S; Vardy J; Clarke S; van Zandwijk N; Klebe S
Asia Pac J Clin Oncol; 2013 Sep; 9(3):273-9. PubMed ID: 23167246
[TBL] [Abstract][Full Text] [Related]
20. Malignant mesothelioma with squamous differentiation.
Tanaka H; Akiyama Y; Kitamura A; Matsumoto N; Tomita M; Kataoka H
Histopathology; 2018 Jun; 72(7):1216-1220. PubMed ID: 29430704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]